PATENT CLAIM ANALYSIS

Application Number: 15944072
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "277100"]

Abstract:
The present invention relates to a method for the preparation of an immunogenic lysate from mesothelioma tumor cells, to such a lysate and to dendritic cells loaded with the lysate, the present invention further relates a pharmaceutical composition comprising such lysate or dendritic cells, to the use of the lysate, and to said loaded dendritic cells or said pharmaceutical composition for use in the prevention or treatment of mesothelioma.

Claim (Index 48):
The immunogenic lysate according to  claim 45 , wherein the mesothelioma tumor cells are derived from humans.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 2.11429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14758153', '10524738', '14247028', '10495511', '12995434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.695852240227033
- 35 USC 102 Novelty (BERT): 0.5517455665343508
- Combined Prediction Score: 0.6814415728577647
- Mean Citation Score: 257.38111200000003
- Max Citation Score: 397.9841
- Similarity Product: 301.023924826932

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test